One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.
about
Update on diagnosis and monitoring of cystic fibrosis-related diabetes mellitus (CFRD)Management of pancreatogenic diabetes: challenges and solutionsEpidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine SocietyLow glycaemic index dietary interventions in youth with cystic fibrosis: a systematic review and discussion of the clinical implications.Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.Targeting the Intracellular Environment in Cystic Fibrosis: Restoring Autophagy as a Novel Strategy to Circumvent the CFTR Defect.Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial.Oral glucose tolerance testing in children with cystic fibrosis.Glucose >200 mg/dL during Continuous Glucose Monitoring Identifies Adult Patients at Risk for Development of Cystic Fibrosis Related Diabetes.Cystic fibrosis related diabetes (CFRD)--the end stage of progressive insulin deficiency.Malnutrition in cystic fibrosis: a review.Screening of glucose metabolism derangements in pediatric cystic fibrosis patients: how, when, why.Insulin therapy in patients with cystic fibrosis in the pre-diabetes stage: a systematic review.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.Glucose derangements in very young children with cystic fibrosis and pancreatic insufficiency.Pharmacological management of cystic fibrosis related diabetes.Targeting postprandial glycaemia in children with diabetes: Opportunities and challenges.Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trialLow-dose insulin therapy in patients with cystic fibrosis and early-stage insulinopenia prevents deterioration of lung function: a 3-year prospective study
P2860
Q26830633-72A16DDA-8080-42C2-A977-C8854BBD8955Q28069386-3A20643F-8B05-47A0-BAEC-8BC503500D23Q34351912-A81C2AB6-4FA0-4ECF-8EEC-0840DABBC5BCQ34351928-4065EC20-75C6-4ECF-A64B-2458D1B476B4Q35942597-78C071D5-4FBF-46BB-AEC8-EC064EF94008Q36388443-002860F5-D588-42BD-A659-BE7624DAEAE4Q36547077-BD75FDF7-FC35-4BF4-BD9E-07401D9B9123Q37364992-34854FC4-CBF3-4092-BCEA-F47A76F77A56Q37377703-0153CBA7-7B52-45F8-A059-51511ADABCECQ37483419-0B232880-EAAE-43D0-A833-BE7AB37C157CQ37882620-7942989D-B140-4BF6-803E-DFDFA3666939Q38156392-7C10CD9E-8180-4D4A-ABD8-AA966BD127BFQ38416187-3A9F77B3-0142-4C3D-A85C-EC80DEA98ACAQ38781600-4BDDC5B1-4F2E-44C4-88AE-8389452CAEA8Q38857042-5A9E24D2-E0D5-4EA4-B2AC-55F6A405DD09Q38980646-581D962E-C3D6-4B3C-AF98-72D91AF79FD0Q42412088-8AAAAEB3-A942-40B3-8724-98962A5A0B14Q47266208-AADBFDD2-0D10-4457-ADEA-7B82422FFC3CQ48123950-B9B16BA7-64D8-4802-AD38-698EAE9A99C7Q52739000-676E3341-AC8A-4681-9895-C89B80EAC0E9Q54265700-69801D6C-8496-4338-BD37-CAE7A8D1D1ABQ58025066-588111AE-DC79-4552-A40E-49BA0698B7D1
P2860
One-year glargine treatment can improve the course of lung disease in children and adolescents with cystic fibrosis and early glucose derangements.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
One-year glargine treatment ca ...... nd early glucose derangements.
@en
One-year glargine treatment ca ...... nd early glucose derangements.
@nl
type
label
One-year glargine treatment ca ...... nd early glucose derangements.
@en
One-year glargine treatment ca ...... nd early glucose derangements.
@nl
prefLabel
One-year glargine treatment ca ...... nd early glucose derangements.
@en
One-year glargine treatment ca ...... nd early glucose derangements.
@nl
P2093
P1433
P1476
One-year glargine treatment ca ...... and early glucose derangements
@en
P2093
Adriana Franzese
Angela Sepe
Gianfranco Mazzarella
Ilaria De Simone
Pasqualina Ferri
Valeria Raia
P304
P356
10.1111/J.1399-5448.2008.00451.X
P577
2009-01-14T00:00:00Z